ZYUS Life Sciences, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public, Subsidiary
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.zyus.com
Unique Treatment of Oncology Pain in Advanced Cancer
Phase 2
Not yet recruiting
- Conditions
- Cancer Pain
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- ZYUS Life Sciences Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06533657
Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation
Phase 1
Completed
- Conditions
- HealthyOsteoarthritis
- Interventions
- Drug: Trichomylin for MADDrug: Placebo for SADDrug: Placebo for MADDrug: Trichomylin for SAD
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- ZYUS Life Sciences Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT04867057
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath